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Case Report
Miliary Tuberculosis Following Transrectal Ultrasonography 
(TRUS)-Guided Prostate Biopsy
Chul Jang Kim, Taichi Sano, Keita Takimoto
Department of Urology, Kohka Public Hospital, Kohka, Japan
Miliary tuberculosis (TB) after transrectal ultrasonography (TRUS)-guided prostate 
biopsy is an extremely rare complication. A 75-year-old patient who presented with high 
fever and cough following TRUS-guided prostate biopsy for his high serum pros-
tate-specific antigen (PSA) level (13.104 ng/ml) was diagnosed with miliary TB after 
clinical, laboratory, and radiological assessments. Histopathological examination of 
the prostate revealed TB with acid-fast bacilli. He was treated with chemotherapy for 
9 months. The patient is now symptom-free, and his post-treatment PSA level was 5.023 
ng/ml. This case is reported to acknowledge the possibility that miliary TB can occur 
as a complication of prostate biopsy if the patient suffers from prostate TB.
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Guided by levels of prostate-specific antigen (PSA), pros-
tate biopsy by transrectal ultrasonography (TRUS) has be-
come a standard method in diagnosing cancer. TRUS-guid-
ed prostate biopsy is relatively safe and is usually well tol-
erated by patients. However, minor complications such as 
hematuria (13-58%), hematospermia (5-45%), or rectal 
hemorrhage (2-37%) or, rarely, major complications such 
as sepsis (0.1-2.2%), urinary tract infection with fever 
(1.4-4.5%), and urinary retention (0.2-2.6%) have been ob-
served [1-7]. This case reports the first case of miliary tu-
berculosis (TB) occurring as a complication of prostate bi-
opsy and emphasizes the possibility of this occurrence if the 
patient suffers from prostate TB.
CASE REPORT
A 75-year-old man underwent TRUS-guided prostate biop-
sy because of a high serum PSA level (PSA: 13.104 ng/ml) 
detected during an examination for difficult urination. His 
medical history revealed pneumoconiosis, which was con-
servatively followed in the outpatient department of respi-
ratory medicine. Urinalysis before the biopsy showed 1 to 
4 red blood cells and 1 to 4 white blood cells per high-power 
field in the sediments. He was given prophylactic anti-
biotics (cefdinir 300 mg/day starting from 1 day before the 
biopsy for a total of 2 days and intravenous cefmetazole so-
dium 1 g during the procedure) before the TRUS-guided 
prostate biopsy. A hard mass without tenderness was pal-
pable in the left lobe of the prostate by digital rectal exami-
nation (DRE). Physical examination of the scrotal contents 
revealed no abnormal findings. The TRUS findings re-
vealed a prostate volume of 25 ml and a 12x16 mm hypo-
echoic lesion in the left peripheral zone of the prostate (Fig. 
1). A fever spike over 38.5
oC began about 18 hours after the 
biopsy. The case was diagnosed as sepsis due to complica-
tion from the TRUS-guided prostate biopsy. He received 
antimicrobial treatment (intravenous piperacillin sodium 
2 g, two times daily) for 5 days. However, the fever spike 
did not improve, and he began to cough 4 days after the 
biopsy. His white blood cell count was 5,200/mm
3, with 
85.5% neutrophils, 0.2% basophils, 10.7% lymphocytes, 
and 3.6% monocytes. C-reactive protein was 13.7 mg/dl. 
Blood and urine cultures were negative for pathogens. A 
chest computed tomography scan showed multiple nodular 
and macular shadows with pleural effusions in bilateral 
lungs, raising a suspicion of miliary TB (Fig. 2). 
　Polymerase chain reaction analyses for TB were positive 
in sputum, gastric washing, and urine, and sputum study 
was negative for Gaffky. The histopathological examina-
tion revealed TB of the prostate in 4 of 8 biopsy specimens Korean J Urol 2011;52:425-427
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FIG. 1. Hypoechoic lesion in the left peripheral zone of the prostate
by transrectal ultrasonography.
FIG. 2. Chest CT scan showing multiple nodular and macular 
shadows with pleural effusions in bilateral lungs.
FIG. 3. Caseous necrosis rimmed with some epithelioid cells and
Langhans’ type giant cells (H&E, x100).
(Fig. 3). By use of the Ziehl-Neelsen stain, acid-fast bacilli 
were detected in the midst of caseous necrosis. Initial treat-
ment for 2 months consisted of rifampicin, isoniazid (INH), 
pyrazinamide, and ethambutol, and additional treatment 
for 7 months consisted of rifampicin and INH. The patient 
was discharged from the hospital 47 days after the prostate 
biopsy. It was uncertain whether the patient had actually 
suffered from pulmonary TB in the past. A follow-up trans-
rectal prostate biopsy was not performed. The patient is 
now symptom-free, and the follow-up DRE revealed that 
the prostate had a smooth surface and ruby consistency 1 
year after the biopsy. The post-treatment PSA level was 
5.023 ng/ml. 
DISCUSSION 
Miliary TB was diagnosed in our patient resulting from the 
hematogenous spread following TRUS-guided prostate 
biopsy. The histopathological examination of the prostate 
biopsy revealed TB with acid-fast bacilli. Predicting pros-
tate TB is very difficult because of its rarity. In a number 
of reported cases, it was diagnosed incidentally by the path-
ologist after a transurethral resection [8]. The clinical char-
acteristics of prostate TB are usually nonspecific. Its main 
presenting symptoms are scrotal lesions, followed by lower 
urinary tract symptoms and painless gross hematuria. 
DRE findings are similar to those in prostate cancer, and 
the TRUS findings of diffuse hypoechoic lesions within the 
peripheral zone of the prostate frequently make it difficult 
to differentiate prostate TB from adenocarcinoma of the 
prostate. In the present case, a TRUS-guided prostate biop-
sy was performed because of the high serum PSA levels in 
our patient. In 18 patients with prostate TB, the median 
PSA level was 2.7 ng/ml (range, 0.3-31 ng/ml). The PSA lev-
el was greater than 4.0 ng/ml in 6 patients (33.3%) [9], 
which suggests that the PSA level might increase owing to 
the inflammatory reaction of TB. Thus, the diagnosis can 
only be confirmed by a prostate biopsy. 
　TB of the prostate is almost always the result of one or 
perhaps successive hematogenous seedings [10]. The pri-
mary site for infection of the genital tract is often the epi-
didymis by hematogenous spread [8]. Lee et al reported 
that 50% of prostate TB is associated with TB of the 
epididymis. This suggested that the etiology and patho-
physiology of these two diseases may be identical or directly 
related [9]. Physical examination of the scrotal contents 
might be useful for determining the possibility of prostate 
TB before the prostate biopsy with precise medical exami-
nation by interview. In addition, it seems that prostate TB 
should be considered in the differential diagnosis of pros-
tate cancer because of the increased numbers of patients 
with human immunodeficiency virus (HIV) or other im-
munocompromised patients. Pneumoconiosis and ad-
vanced age were risk factors for developing miliary TB in 
our patient. This case is presented to acknowledge the pos-Korean J Urol 2011;52:425-427
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sibility that miliary TB can occur as a complication of pros-
tate biopsy if the patient suffers from prostate TB.
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